Items where Division is "Current Faculties > Faculty of Medicine > School of Healthcare, Enterprise and Innovation > SHTAC
School of Healthcare, Enterprise and Innovation > SHTAC" and Year is 2023
 | Up a level |
Number of items: 10.
Efgartigimod for treating generalised myasthenia gravis: a single technology appraisal - Fay Chinnery, Lois Woods, Keith Cooper, Bogdan Grigore, David Alexander Scott and Joanna Picot
Type: Monograph
| 2023
| National Institute for Health and Care Excellence
Assessing micro- vs macro-costing approaches for treating appendicitis in children with appendicectomy or non-operatively - Maria Chorozoglou, Isabel Reading, Simon Eaton, Shehryer Naqvi, Caroline Pardy, Keren Sloan, Christina Major, Natasha Demellweek and Nigel J. Hall
Type: Article
| 2023
PARP inhibitors for metastatic urothelial carcinoma: a systematic review of efficacy and safety - Simon J. Crabb, Taha Khalid, Lois Woods, Geoff Frampton and Jonathan Shepherd
Type: Review
| 2023
Patient centred outcomes following non-operative treatment or appendicectomy for uncomplicated acute appendicitis in children - Nigel Hall, Frances C. Sherratt, Simon Eaton, Erin Walker, Mary Chorozoglou, Lucy Beasant, Michael P. Stanton, Harriet J Corbett, Dean Rex, Natalie J Hutchings, Elizabeth Dixon, Esther Crawley, Jane Blazeby, Bridget Young and Isabel Reading
Type: Article
| 2023
Darolutamide with androgen deprivation therapy and docetaxel for treating hormone-sensitive metastatic prostate cancer: a single technology appraisal - Lorna Hazell, Keith Cooper, Fay Chinnery, Karen Pickett, David Alexander Scott and Jonathan Shepherd
Type: Monograph
| 2023
| National Institute for Health and Care Excellence
| Item not available on this server.
Patient decision support resources inform decisions about cancer susceptibility genetic testing and risk management: a systematic review of patient impact and experience - Kelly Kohut, Kate Morton, Lesley Turner, Jonathan Shepherd, Vicky Fenerty, Lois Woods, Chloe Grimmett, Diana M. Eccles and Claire Foster
Type: Article
| 2023
Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy: a single technology appraisal - Joanne Lord, Lois Woods, Marcia Tomie Takahashi and Geoff Frampton
Type: Monograph
| 2023
| National Institute for Health and Care Excellence
Mirikizumab for treating moderately to severely active ulcerative colitis: a single technology appraisal - Karen Pickett, Neelam Kalita, Emma Maund, Jaime Peters, Marcia Takahashi and Joanna Picot
Type: Monograph
| 2023
| National Institute for Health and Care Excellence
Daratumumab in combination with bortezomib and dexamethasone for treating relapsed or refractory multiple myeloma (review of TA573): a single technology appraisal - Inês Ribeiro, Emma Maund, Neelam Kalita, David Alexander Scott and Jo Picot
Type: Monograph
| 2023
| National Institute for Health and Care Excellence
| Item not available on this server.
Bimekizumab for treating active psoriatic arthritis: a single technology appraisal - David Alexander Scott, Karen Pickett, Keith Cooper, Fay Chinnery and Joanna Picot
Type: Monograph
| 2023
| National Institute for Health and Care Excellence
| Item not available on this server.